Leerink Partners Maintains Outperform on Veracyte, Raises Price Target to $40

Benzinga · 10/17 14:59
Leerink Partners analyst Puneet Souda maintains Veracyte (NASDAQ:VCYT) with a Outperform and raises the price target from $35 to $40.